Skip to main content
. 2018 May 2;136(7):786–793. doi: 10.1001/jamaophthalmol.2018.1804

Figure 2. Functional and Anatomic Outcomes.

Figure 2.

A, Change in best-corrected visual acuity (BCVA) from baseline to week 52 (last observation carried forward [full analysis set]). B, Change in central subfield thickness (CST) from baseline to week 52. Last observation carried forward (fullanalysis set [FAS]). C, Proportion of participants with absence of fluid detected on optical coherence tomography (OCT) over 52 weeks (observed cases [safety analysis set]). ETDRS indicates Early Treatment Diabetic Retinopathy Study; IAI, intravitreal aflibercept; PDT, photodynamic therapy.